American Society of Hirudotherapy

Cyclical Mastalgia (Investigational Adjunct)

Investigational adjunct for severe cyclical mastalgia refractory to conventional therapy; no clinical study identified; reassurance, lifestyle modification, and selective danazol/tamoxifen remain primary.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 17, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for cyclical mastalgia. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational with no clinical study identified; only chest-wall placement is considered.
What evidence exists?
Tier C (investigational). No clinical study of leech therapy for cyclical mastalgia was identified. Cyclical mastalgia is most often related to physiologic premenstrual changes and is managed per ACOG and breast-specialty guidance: reassurance after malignancy exclusion, proper bra support, evening primrose oil (modest evidence), and for severe refractory cases short-course tamoxifen or danazol with substantial side effects. Direct breast leech application carries risk of nipple/areolar discomfort and infection adjacent to ductal structures.
Main risks
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Bruising and tenderness over the chest wall for 5 to 10 days
  • Local skin infection or, rarely, Aeromonas infection
  • Allergic reaction to leech saliva
  • Substantial bleeding and infection risk if a practitioner inappropriately places a leech on breast tissue or the nipple-areolar complex (this is not appropriate)
  • Failure to detect underlying breast pathology if imaging workup is incomplete
  • Delay of bra-fit correction, lifestyle modification, and short-course tamoxifen, which are evidence-based
  • Worsening of symptoms with no benefit
Who should not consider this
  • Patients with suspicion of breast malignancy (BI-RADS 4 or 5)
  • Patients with active mastitis or breast abscess
  • Pregnant or lactating patients
  • Patients with breast implants in place at the proposed site
  • Patients with lymphedema after breast surgery
  • Anyone offered direct breast or nipple-areolar placement (this is not appropriate)
  • Patients on anticoagulants or with anemia
  • Anyone with imaging not yet performed if age over 30 or focal mass
  • Patients with suspected inflammatory breast cancer (urgent oncology referral)
What to ask your clinician
  • Has breast imaging been performed (clinical breast exam, mammogram, ultrasound) to exclude pathology?
  • Have I been properly bra-fitted?
  • Have I trialed evening primrose oil, caffeine reduction, and lifestyle modification?
  • Has short-course luteal-phase tamoxifen been considered for severe disease?
  • Where exactly will the leech be placed — confirm chest-wall skin lateral to breast tissue?
  • What is the realistic expected benefit, given that no clinical study of leech therapy for mastalgia has been identified?
When to seek urgent care
  • A new lump or persistent focal area of pain or thickening in the breast
  • Skin changes (peau d'orange, dimpling), nipple inversion or discharge
  • Spreading redness, warmth, or swelling of the breast (mastitis or inflammatory breast cancer)
  • Fever above 38.0 C / 100.4 F or chills
  • Bleeding from a bite site lasting more than 24 hours
  • Spreading redness, warmth, pus, or red streaks at any bite site
  • Hives, throat tightness, or breathing difficulty

What this does NOT mean

  • It is not placed on breast tissue or the nipple-areolar complex.
  • It does not detect or treat any breast pathology — imaging workup is separate and primary.
  • It does not substitute for proper bra fitting, lifestyle modification, or short-course tamoxifen in severe disease.
  • No clinical study of leech therapy for mastalgia was identified, so any benefit beyond reassurance and lifestyle measures is unknown.

Clinical Profile

Category
Gynecologic
ICD-10
N64.4
Safety tier
Medium

Evidence Summary

Cyclical mastalgia (most often related to physiologic premenstrual changes) is managed per ACOG and breast-specialty guidance with reassurance after malignancy exclusion, supportive bras, evening primrose oil (modest evidence), and, for severe refractory cases, danazol or tamoxifen with substantial side effects. No clinical study of leech therapy for cyclical mastalgia (of any design) was identified in PubMed, Europe PMC, ClinicalTrials.gov, the Baskova and Isakhanyan 2004 monograph, or Russian-language searches; use is investigational and mechanistic only, and the honest evidence grade is D. Any proposed lymphatic or antiinflammatory rationale is theoretical. Direct leech application carries risk of nipple/areolar discomfort and infection adjacent to ductal structures.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Suspected breast malignancy (BI-RADS 4/5)
  • Active mastitis or breast abscess
  • Pregnancy or breastfeeding
  • Breast implants in place at proposed site
  • Lymphedema after breast surgery
  • Direct breast or nipple-areolar placement
  • Untreated breast pathology (cyst, mass, suspicious imaging)
  • Inflammatory breast cancer suspected (urgent oncology referral)

Related Conditions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.